We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.
See our privacy policy for more information on the use of your personal data.
Manage preferences for further information and to change your choices.
From: Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype
Gene
Protein
Cation
Antiarrhythmic
CACNA1H
Cav.3.2
Ca2+
verapamil
nifedipine
CACNB1
CaB1
CACNB2
CaB2
CACNB3
CaB3
KCNS3
Kv9
K+
amiodarone
KCNH2
hERG1.3
KCNQ2
Kv7.2
SCN1B
NaB1
Na+
flecainide
SCN2A
Nav1.2